Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.
Return On Capital Employed Overview: Omeros
Omeros (NASDAQ:OMER) reported Q1 sales of $21.06 million. Earnings fell to a loss of $30.61 million, resulting in a 9.47% decrease from last quarter. In Q4, Omeros brought in $10.63 million in sales but lost $33.82 million in earnings.
WBB Securities Maintains Strong Buy on Omeros, Raises Price Target to $100
WBB Securities analyst Steve Brozak maintains Omeros (NASDAQ:OMER) with a Strong Buy and raises the price target from $75 to $100.
Omeros’ Narsoplimab Associated With Improvement In Organ Function In Stem Cell Transplant Patients
Omeros Corporation (NASDAQ:OMER) has announced the presentation of data on organ function improvement from its pivotal trial of narsoplimab for the…
Omeros Highlights Presentation Of Narsoplimab Pivotal Trial Data In Oral Presentation At 2021 Annual Congress Of European Hematology Association
Data on Organ Function Improvement Presented by Chief of Adult Bone Marrow Transplant Service at Memorial Sloan Kettering --
Omeros Corporation (NASDAQ:OMER) today announced that data on organ function improvement from
60 Biggest Movers From Yesterday
Gainers
Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08 on Thursday.
Earnings Scheduled For May 10, 2021
Companies Reporting Before The Bell
• Revlon (NYSE:REV) is likely to report earnings for its first quarter.
• Bluegreen Vacations (NYSE:BVH) is expected to report earnings for its first quarter.
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.